Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sweezey, N.
Right arrow Articles by Fellows, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sweezey, N.
Right arrow Articles by Fellows, K.

Chest, Vol 97, 1322-1326, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Bronchial artery embolization for severe hemoptysis in cystic fibrosis

NB Sweezey and KE Fellows
Department of Pediatrics, Harvard Medical School, Boston.

We studied the long-term outcome after BAE for life-threatening hemoptysis in patients with CF. Data from pulmonary function tests were available for 18 of the 25 patients followed. A case-control comparison revealed that these 18 patients died sooner than hemoptysis-free patients with CF matched for age, sex, and pulmonary function (p less than 0.02), with the excess mortality occurring within the first three months after BAE. Of all 25 patients followed, six died of cardiorespiratory failure within three months of BAE; in two of them, hemoptysis was a contributing cause of death. The 19 patients who lived more than three months after BAE had a mean survival after embolization of 3.5 years (five were still alive at the end of the study). Most patients experienced long intervals (greater than 1 year) free of major hemoptysis. Extended follow-up (mean, 35 months) revealed a higher incidence of recurrent severe bleeding than previously reported for 13 of these patients followed a mean of 11 months. Repeat BAE for severe recurrence was performed successfully in eight of nine patients, without complication.


This article has been cited by other articles:


Home page
 RadiologyHome page
J. Barben, D. Robertson, A. Olinsky, and M. Ditchfield
Bronchial Artery Embolization for Hemoptysis in Young Patients with Cystic Fibrosis
Radiology, July 1, 2002; 224(1): 124 - 130.
[Abstract] [Full Text]

Home page
 ChestHome page
M. Antonelli, F. Midulla, G. Tancredi, F. M. Salvatori, E. Bonci, G. Cimino, and I. Flaishman
Bronchial Artery Embolization for the Management of Nonmassive Hemoptysis in Cystic Fibrosis
Chest, March 1, 2002; 121(3): 796 - 801.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. A. Chapman, M. D. Holmes, and D. J. Taylor
Unilateral Diaphragmatic Paralysis Following Bronchial Artery Embolization for Hemoptysis
Chest, July 1, 2000; 118(1): 269 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. M. BRINSON, P. G. NOONE, M. A. MAURO, M. R. KNOWLES, J. R. YANKASKAS, J. S. SANDHU, and P. F. JAQUES
Bronchial Artery Embolization for the Treatment of Hemoptysis in Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1951 - 1958.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. A. Coss-Bu, R. C. Sachdeva, J. T. Bricker, G. M. Harrison, and L. S. Jefferson
Hemoptysis: A 10-Year Retrospective Study
Pediatrics, September 1, 1997; 100(3): e7 - e7.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American College of Chest Physicians.